reported that GLS2 expression was able to increase the EMT markers as well as cancer cell migration and invasion partly through the regulation of ERK and ZEB1 in breast cancer (92), indicating a positive induction of EMT by GLS2. This evidence concerns the gene GLS2 and breast carcinoma.